New 13D23
New 13G71
Stated intents3
The week of 2025-12-01, 23 holders filed a new Schedule 13D and 71 a new Schedule 13G reporting 5% or more of a company, and 3 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-12-05 | RTB Digital, Inc. | Rtb Digital Inc. | 100% | SCHEDULE 13D |
| 2025-12-03 | BTCS Labs Inc. | Charles W. Allen | 80% | SCHEDULE 13D |
| 2025-12-01 | Datavault Ai Inc. | Scilex Holding Company | 47.99% | SCHEDULE 13D |
| 2025-12-02 | Brookfield Real Estate Income Trust Inc. | Brookfield Corporation | 32.26% | SCHEDULE 13D |
| 2025-12-03 | SC II Acquisition Corp. | SC Capital II Sponsor LLC | 30.75% | SCHEDULE 13D |
| 2025-12-04 | Invest Green Acquisition Corp | IG SPAC Sponsor LLC | 26.1% | SCHEDULE 13D |
| 2025-12-04 | General Purpose Acquisition Corp. | General Purpose Acquisition Corp Services LLC | 21% | SCHEDULE 13D |
| 2025-12-02 | Blue Water Acquisition Corp. III | Yorkville BW Acquisition Sponsor, LLC | 20.9% | SCHEDULE 13D |
| 2025-12-03 | Health Catalyst, Inc. | First Light Asset Management, LLC | 19.68% | SCHEDULE 13D |
| 2025-12-04 | Fusion Fuel Green PLC | Frederico Figueira de Chaves | 17.2% | SCHEDULE 13D |
| 2025-12-04 | Fusion Fuel Green PLC | John-Paul Backwell | 16.6% | SCHEDULE 13D |
| 2025-12-02 | Barnwell Industries Inc | Radoff Bradley Louis | 9.1% | SCHEDULE 13D |
| 2025-12-05 | Universal Technical Institute, Inc. | Coliseum Capital Management, LLC | 7.3% | SCHEDULE 13D |
| 2025-12-05 | Powerdyne International, Inc. | Foster Eric F. | 7.2% | SCHEDULE 13D |
| 2025-12-04 | Mobile-health Network Solutions | Indopacific Health Investment Corporation Pte. Ltd. | 6.43% | SCHEDULE 13D |
| 2025-12-03 | Globus Maritime Ltd | Goldenmare Ltd | 6.2% | SCHEDULE 13D |
| 2025-12-01 | Noodles & Company | Galloway Capital Partners, LLC | 6.01% | SCHEDULE 13D |
| 2025-12-03 | TrueCar, Inc. | AutoNation, Inc. | 6% | SCHEDULE 13D |
| 2025-12-01 | Netcapital Inc. | Strategic EP, LLC | 5.8% | SCHEDULE 13D |
| 2025-12-01 | Ashland Inc. | Standard Investments LLC | 5.7% | SCHEDULE 13D |
| 2025-12-01 | Enviri LLC | D. E. Shaw & Co., L.P. | 5.4% | SCHEDULE 13D |
| 2025-12-05 | National Presto Industries Inc | Albion River Management LLC | 5.07% | SCHEDULE 13D |
| 2025-12-01 | Power REIT | Posner Henry Iii | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-12-04 | iShares Enhanced Large Cap Core Active ETF | BlackRock Portfolio Management LLC | 93.8% | SCHEDULE 13G |
| 2025-12-04 | iShares MSCI UAE ETF | BlackRock Portfolio Management LLC | 90.9% | SCHEDULE 13G |
| 2025-12-04 | iShares MSCI UAE ETF | BlackRock Portfolio Management LLC | 90.9% | SCHEDULE 13G |
| 2025-12-04 | MaxsMaking Inc. | ThriveNova Inc. | 89.3% | SCHEDULE 13G |
| 2025-12-04 | iShares MSCI UAE ETF | BlackRock Portfolio Management LLC | 66.7% | SCHEDULE 13G |
| 2025-12-04 | iShares MSCI UAE ETF | BlackRock Portfolio Management LLC | 66.7% | SCHEDULE 13G |
| 2025-12-05 | Robot Consulting Co., Ltd. | Hidetoshi Yokoyama | 61.9% | SCHEDULE 13G |
| 2025-12-05 | First Trust Exchange-Traded Fund VI | First Trust Portfolios L.P. | 59.29% | SCHEDULE 13G |
| 2025-12-01 | Zhibao Technology Inc. | Beijing Koala Kunlu Internet Industry Investment Fund (Limited Partnership) | 22.2% | SCHEDULE 13G |
| 2025-12-05 | Carlyle Credit Income Fund | Karpus Management, Inc. | 22.09% | SCHEDULE 13G |
| 2025-12-05 | Damora Therapeutics Inc | Ikarian Capital, LLC | 21.5% | SCHEDULE 13G |
| 2025-12-04 | Harrison Global Holdings Inc. | Luk Keung Kong | 16.76% | SCHEDULE 13G |
| 2025-12-04 | Harrison Global Holdings Inc. | Hongying Li | 16.76% | SCHEDULE 13G |
| 2025-12-04 | Harrison Global Holdings Inc. | Anyuan Ai | 16.76% | SCHEDULE 13G |
| 2025-12-04 | Harrison Global Holdings Inc. | Man Kong | 16.76% | SCHEDULE 13G |
| 2025-12-03 | KALA BIO, Inc. | Oxford Finance LLC | 16.5% | SCHEDULE 13G |
| 2025-12-05 | Yimutian Inc. | Beijing Fengmu Enterprise Consulting Center (Limited Partnership) | 16.1% | SCHEDULE 13G |
| 2025-12-03 | Calamos ETF Trust | Truist Financial Corp | 15.3% | SCHEDULE 13G |
| 2025-12-05 | Invesco Equal Weight 0-30 Year Treasury ETF | Invesco Ltd. | 15.2% | SCHEDULE 13G |
| 2025-12-05 | Damora Therapeutics Inc | Fmr LLC | 15% | SCHEDULE 13G |
| 2025-12-05 | Beta Technologies, Inc. | Fmr LLC | 15% | SCHEDULE 13G |
| 2025-12-05 | Inovio Pharmaceuticals, Inc. | Fmr LLC | 14.8% | SCHEDULE 13G |
| 2025-12-03 | Republic Airways Holdings Inc. | Delta Air Lines, Inc. | 14.4% | SCHEDULE 13G |
| 2025-12-05 | Omnicom Group Inc | State Street Corporation | 13.8% | SCHEDULE 13G |
| 2025-12-05 | Willscot Holdings Corporation | Fmr LLC | 13.3% | SCHEDULE 13G |
| 2025-12-03 | Qnity Electronics Inc | The Vanguard Group | 13.05% | SCHEDULE 13G |
| 2025-12-02 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 12.92% | SCHEDULE 13G |
| 2025-12-03 | Japan Smaller Capitalization Fund, Inc. | Lazard Asset Management LLC | 12.3% | SCHEDULE 13G |
| 2025-12-05 | SI-BONE, Inc. | Mathew P. Arens | 11.92% | SCHEDULE 13G |
| 2025-12-04 | Caesars Entertainment, Inc. | BlackRock, Inc. | 11.5% | SCHEDULE 13G |
| 2025-12-05 | Strive, Inc. | Fmr LLC | 11% | SCHEDULE 13G |
| 2025-12-04 | Commercial Bancgroup Inc | AllianceBernstein L.P. | 10.2% | SCHEDULE 13G |
| 2025-12-01 | Clearmind Medicine Inc. | L.I.A. Pure Capital Ltd. | 9.99% | SCHEDULE 13G |
| 2025-12-01 | Clearmind Medicine Inc. | Capitalink Ltd. | 9.99% | SCHEDULE 13G |
| 2025-12-01 | MingZhu Logistics Holdings Ltd | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2025-12-04 | New America Acquisition I Corp. | YA II PN, Ltd. | 9.99% | SCHEDULE 13G |
| 2025-12-05 | Pasithea Therapeutics Corp. | Vivo Opportunity Fund Holdings, L.P. | 9.99% | SCHEDULE 13G |
| 2025-12-01 | Cn Energy Group. Inc. | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2025-12-05 | Pasithea Therapeutics Corp. | Squadron Capital Management LLC | 9.9% | SCHEDULE 13G |
| 2025-12-03 | Total Return Securities Fund | Css LLC | 9% | SCHEDULE 13G |
| 2025-12-04 | SciSparc Ltd. | Nissim Daniel | 8.76% | SCHEDULE 13G |
| 2025-12-03 | Willow Lane Acquisition Corp. | Islet Management, LP | 8.72% | SCHEDULE 13G |
| 2025-12-03 | SC II Acquisition Corp. | Feis Equities LLC | 8.61% | SCHEDULE 13G |
| 2025-12-02 | SC II Acquisition Corp. | Linden Capital L.P. | 8.6% | SCHEDULE 13G |
| 2025-12-04 | SC II Acquisition Corp. | Harraden Circle Investments, LLC | 8.48% | SCHEDULE 13G |
| 2025-12-01 | CalciMedica, Inc. | Chernett Jorey | 7.9% | SCHEDULE 13G |
| 2025-12-03 | BranchOut Food Inc. | Bard Associates Inc | 7.7% | SCHEDULE 13G |
| 2025-12-04 | Able View Global Inc. | Alta Partners LLC | 7.6% | SCHEDULE 13G |
| 2025-12-04 | Forge Global Holdings, Inc. | Vince Gubitosi | 7.24% | SCHEDULE 13G |
| 2025-12-02 | BTQ Technologies Corp. | Geneva Insurance Group (Barbados) Inc. | 6.4% | SCHEDULE 13G |
| 2025-12-02 | Jasper Therapeutics, Inc. | Anders Hove | 6.4% | SCHEDULE 13G |
| 2025-12-04 | Boundless Bio, Inc. | Kenneth Griffin | 6.4% | SCHEDULE 13G |
| 2025-12-01 | CorMedix Inc. | Deep Track Capital, LP | 6.29% | SCHEDULE 13G |
| 2025-12-04 | VisionSys AI Inc | Arena Investors, LP | 6.2% | SCHEDULE 13G |
| 2025-12-04 | AB Private Lending Fund | PM Alpha DAC | 6.12% | SCHEDULE 13G |
| 2025-12-05 | Zapata Quantum, Inc. | Andretti Autosport Holding Company, LLC | 5.8% | SCHEDULE 13G |
| 2025-12-03 | Benitec Biopharma Inc. | RA Capital Management, L.P. | 5.5% | SCHEDULE 13G |
| 2025-12-04 | Invest Green Acquisition Corp | Linden Advisors LP | 5.5% | SCHEDULE 13G |
| 2025-12-05 | Bitcoin Infrastructure Acquisition Corp Ltd | Linden Capital L.P. | 5.5% | SCHEDULE 13G |
| 2025-12-02 | Granite Real Estate Investment Trust | Royal Bank of Canada | 5.49% | SCHEDULE 13G |
| 2025-12-03 | Verrica Pharmaceuticals Inc. | Affinity Asset Advisors, LLC | 5.47% | SCHEDULE 13G |
| 2025-12-01 | Park Hotels & Resorts Inc. | Beit Roger J | 5.2% | SCHEDULE 13G |
| 2025-12-02 | Wix.com Ltd. | Senvest Management, LLC | 5.2% | SCHEDULE 13G |
| 2025-12-01 | Chord Energy Corp | Key Group Long Term Investments LP | 5.1% | SCHEDULE 13G |
| 2025-12-03 | Comstock Resources, Inc. | Key Group Long Term Investments LP | 5.1% | SCHEDULE 13G |
| 2025-12-04 | Norwood Financial Corp | Bay Pond Partners, L.P. | 5.1% | SCHEDULE 13G |
| 2025-12-05 | Smartstop Self Storage Reit | Prudential Financial Inc | 5.1% | SCHEDULE 13G |
| 2025-12-05 | Enveric Biosciences, Inc. | Braeden Lichti | 5.01% | SCHEDULE 13G |
| 2025-12-05 | Enveric Biosciences, Inc. | Braeden Lichti | 5.01% | SCHEDULE 13G |
| 2025-12-02 | D-MARKET Electronic Services & Trading | VR Global Partners, L.P. | 5% | SCHEDULE 13G |
| 2025-12-03 | InfuSystem Holdings, Inc | Minerva Advisors LLC | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-12-02 | Neuphoria Therapeutics Inc. | Lynx1 Capital Management LP intent stated | 16.3% | SCHEDULE 13D/A |
| 2025-12-05 | Carver Bancorp Inc | Mann Barry James intent stated | 9.6% | SCHEDULE 13D/A |
| 2025-12-05 | Alaunos Therapeutics, Inc. | Price Adrian intent stated | 8.6% | SCHEDULE 13D/A |
Download this data (CSV)97 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.